Management Devices Market was valued at USD 1.53 billion in 2023 and is
anticipated to project impressive growth in the forecast period with a CAGR of 4.77%
through 2029. Due to various factors, there is a growing demand for urolithiasis management
devices in the market. One significant contributor to this demand is the
increasing global prevalence of urolithiasis. According to data from the
European Association of Urology, the occurrence of urinary stones varies from
1% to 20%. Developed nations like Canada, Sweden, and the United States exhibit
a notably higher prevalence of renal stones, exceeding 10%. A 2021 report from
the British Association of Urological Surgeons confirms the commonality of
kidney stones, with an 8% likelihood of developing in patients undergoing a CT
scan. The incidence of kidney stones has been on a continuous rise since the
early 20th century. Furthermore, it is estimated that 9% of individuals will
experience symptoms related to stone formation at some point in their lifetime.
Key Market Drivers
Increasing Prevalence of Urolithiasis
Urolithiasis, commonly known as kidney stones, has
emerged as a prevalent and escalating health concern, impacting millions of
individuals worldwide. As the incidence of this painful condition continues to
rise, so does the demand for cutting-edge urolithiasis management devices.
Urolithiasis is characterized by the formation of
solid mineral masses within the urinary tract, often leading to intense pain
and discomfort for those affected. This condition affects people of all ages
and backgrounds, with the potential to significantly diminish their quality of
life. According to data from medical organizations such as the European
Association of Urology, the global prevalence of kidney stones ranges from 1%
to 20%. Some developed nations, including Canada, Sweden, and the United States,
have even reported rates surpassing 10%.
The foremost catalyst behind the surging demand for
urolithiasis management devices is the sheer prevalence of kidney stones. As
the number of individuals suffering from urolithiasis continues to grow, there
is an urgent need for effective and efficient management tools. Patients and
healthcare providers alike are seeking solutions that can alleviate the pain
and complications associated with kidney stones.
The healthcare industry has witnessed remarkable
advancements in the field of urology. These innovations have given rise to an
array of sophisticated urolithiasis management devices that offer minimally
invasive and precise methods for stone removal. Technologies such as laser
lithotripters and advanced endoscopic tools have revolutionized treatment
options, attracting both patients and healthcare professionals.
With increased access to information and healthcare
education, patients are more informed about urolithiasis. This empowerment
enables them to make informed decisions about their treatment. Patients are
increasingly seeking out the latest and most effective urolithiasis management
devices that can provide quicker recovery times and reduce discomfort during
the treatment process.
The growth in urolithiasis cases has not gone
unnoticed by the investment community. As the demand for urolithiasis
management devices continues to rise, it presents an appealing investment
opportunity for medical device manufacturers and healthcare technology
companies. This, in turn, fuels research and development efforts aimed at
creating even more innovative and effective devices for managing urolithiasis.
Public health initiatives and government programs
have been launched in many regions to address the rising incidence of kidney
stones. These initiatives often include preventive measures, awareness
campaigns, and efforts to improve access to advanced urolithiasis management
devices. Such endeavors further contribute to the growth of the market.
The increasing prevalence of urolithiasis places a
significant burden on healthcare systems globally. In response, healthcare
providers are actively seeking efficient and cost-effective urolithiasis
management devices to streamline patient care and reduce the economic strain
associated with this condition.
Advancements in Medical Technology
Urolithiasis, commonly known as kidney stones, is a
condition that affects millions of people worldwide, causing severe pain and discomfort.
As the incidence of kidney stones continues to rise, so does the demand for
innovative urolithiasis management devices.
Advancements in medical technology have led to the
development of minimally invasive treatment options for urolithiasis. These
innovations are transforming the way healthcare providers manage kidney stones.
Techniques such as laser lithotripsy and advanced endoscopic tools allow for
precise and less invasive methods of stone removal. Patients are increasingly
seeking these treatments due to their effectiveness and the reduced discomfort
and recovery times they offer.
The early and accurate diagnosis of urolithiasis is
critical for timely intervention. Advanced diagnostic imaging technologies,
such as high-resolution CT scans and ultrasound, have become indispensable
tools for healthcare providers. These technologies not only enable quicker and
more precise diagnosis but also aid in treatment planning, leading to the
increased demand for urolithiasis management devices.
Advancements in medical technology have not only
improved the effectiveness of urolithiasis management devices but also enhanced
the overall patient experience. These devices are designed with patient comfort
and safety in mind, offering less invasive procedures, reduced pain, and
shorter recovery times. As a result, patients are more inclined to choose these
devices for their urolithiasis management, driving the market's growth.
Robotic-assisted surgery has made significant
strides in urology and has become a game-changer in the management of
urolithiasis. Robots like the da Vinci Surgical System enable surgeons to
perform highly precise and minimally invasive procedures with enhanced
dexterity and control. This technological advancement has not only improved
treatment outcomes but also increased the demand for robotic-assisted
urolithiasis management devices.
The integration of telemedicine and remote patient
monitoring into urology practices has further expanded the reach of
urolithiasis management devices. Patients can now access consultations,
follow-up care, and treatment recommendations remotely, thanks to telehealth
technologies. This accessibility has made urolithiasis management more
convenient and has created new opportunities for the adoption of these devices.
Rising Awareness and Education
Urolithiasis, or kidney stones, is a common
urological condition that affects millions of people worldwide. As the
incidence of kidney stones continues to rise, an essential factor driving the
growth of the global urolithiasis management devices market is the increasing
awareness and education surrounding this condition.
Increasing awareness and education about
urolithiasis have contributed significantly to the growth of urolithiasis
management devices. When individuals are informed about the causes, symptoms,
and potential complications of kidney stones, they are more likely to seek
medical attention and early diagnosis. This, in turn, creates a heightened
demand for management devices as patients and healthcare providers prioritize
Informed patients are empowered patients. As more
people become educated about urolithiasis through various sources such as
healthcare professionals, the internet, and patient advocacy groups, they are
better equipped to make decisions regarding their healthcare. This includes
choosing the most advanced and effective urolithiasis management devices
available, thus contributing to the market's growth.
Awareness and education are not only about
understanding the condition but also about preventing it. As people become
aware of the risk factors for kidney stones, they are more likely to adopt
preventive measures, such as staying well-hydrated and maintaining a healthy
diet. This proactive approach can reduce the incidence of kidney stones and the
need for management devices. However, when needed, these devices are seen as a
crucial part of the solution.
Rising awareness and education help to remove the
stigma associated with urolithiasis. When individuals openly discuss their
experiences and seek information, it contributes to reducing the embarrassment
often linked to this condition. Consequently, more individuals are likely to
seek treatment, and healthcare providers are encouraged to employ advanced
urolithiasis management devices.
The growth of urolithiasis management devices is
not solely dependent on patient awareness but also on the education of
healthcare providers. By staying informed about the latest advances in
urolithiasis management, healthcare professionals are better equipped to
recommend and utilize these devices, further promoting their adoption and use.
Patient advocacy and support groups play a vital
role in raising awareness about urolithiasis. These organizations help
individuals connect, share their experiences, and access valuable information.
They also often collaborate with healthcare professionals and device
manufacturers to drive awareness and education, ultimately increasing the
demand for urolithiasis management devices.
Patient Experience and Expectations
Patients today are seeking healthcare experiences
that are centered around their needs and preferences. This shift towards
patient-centered care has driven the development of urolithiasis management
devices that prioritize patient experience. These devices offer less invasive
procedures, reduced pain, and quicker recovery times, aligning with patient
expectations for comfort and convenience.
The pain associated with kidney stones is often
severe and unforgettable. Patients experiencing kidney stone episodes have high
expectations for minimally invasive treatments that alleviate their discomfort.
Urolithiasis management devices that prioritize patient comfort by reducing
pain during procedures are met with enthusiasm, contributing to the growth of the
Patients are no longer content with extended
recovery times and downtime. Urolithiasis management devices that enable
quicker recovery to have become highly sought after. Patients expect to resume
their normal activities as soon as possible, and devices that offer this
advantage are in high demand.
Patients anticipate safe and effective treatments
with minimal complications. Urolithiasis management devices that meet these
expectations not only enhance patient satisfaction but also encourage the
adoption of these devices by healthcare providers and medical facilities.
Patients are increasingly looking for personalized
treatment plans that cater to their unique needs. Advanced urolithiasis
management devices are designed to offer tailored solutions, considering
factors such as stone size and location. These devices meet the expectation for
personalized care and contribute to the market's growth.
In today's tech-savvy world, patients expect
healthcare solutions to be technologically advanced. Urolithiasis management
devices that incorporate state-of-the-art technologies such as laser
lithotripsy and robotic-assisted surgery align with patient expectations for
Download Free Sample Report
Key Market Challenges
High Treatment Costs
Urolithiasis management can be expensive,
particularly in cases requiring surgical intervention. The cost of urolithiasis
management devices, surgical procedures, hospital stays, and follow-up care can
place a significant financial burden on patients. As a result, affordability
remains a major concern for individuals seeking treatment and the healthcare
systems that serve them.
Limited Access to Advanced Technology
Access to advanced urolithiasis management devices
and technology is not uniform across all regions. Patients in underserved areas
may have limited access to the latest treatment options, which can result in
disparate healthcare outcomes. Bridging this access gap remains a challenge for
ensuring equitable care.
Urolithiasis management is not always consistent
across different demographics. Disparities may exist in terms of access to
care, the choice of management devices, and quality of treatment, resulting in
uneven healthcare outcomes. Addressing these disparities is vital to ensure
that all patients receive optimal care.
Key Market Trends
Innovative Urolithiasis Devices
The market is witnessing a surge in innovative
urolithiasis management devices. These devices are designed to provide more
precise, less invasive, and effective treatment options. Examples include
high-tech lithotripters and specialized endoscopes, which allow healthcare
providers to address kidney stones with increased precision.
Data-driven approaches are increasingly influencing
urolithiasis management. The collection and analysis of data related to patient
outcomes, treatment efficacy, and preventive measures are guiding healthcare
decisions. This data-centric approach is valuable for improving the quality of
care and enhancing research and development efforts.
The concept of patient-centered care is growing in
prominence. Patients are no longer just recipients of care but active
participants in their treatment decisions. Healthcare providers are
increasingly involving patients in shared decision-making, addressing their
preferences and needs in the treatment process.
Treatment Type Insights
Based on the category of Treatment Type, the
intracorporeal lithotripsy sector emerged as the dominant force in the market,
claiming the largest portion of revenue in 2023. It is poised to exhibit the
most rapid CAGR throughout the projected period. Intracorporeal lithotripsy
entails the use of an endoscope to visualize stones and simultaneously
disintegrate them into manageable fragments using laser technology. This method
is typically employed for patients with large stones who are not suitable
candidates for Extracorporeal Shock Wave Lithotripsy (ESWL). Intracorporeal
lithotripsy treatments boast an impressive stone-free success rate of nearly
95% and involve minimal implantation. These procedures, performed under
anesthesia, are readily accessible in medical facilities worldwide. Despite
being an invasive approach, intracorporeal lithotripsy delivers remarkable
stone-free outcomes, requires less time than ESWL, and is associated with
minimal to no apparent side effects. Consequently, it is expected to become the
preferred method for stone removal in the foreseeable future.
Conversely, in 2023, the ESWL segment secured a
significant share of the revenue. ESWL remains a widely used, minimally
invasive treatment due to its accessibility and cost-effectiveness. This
technique primarily employs shock waves to break down stones with diameters
ranging from 4 mm to 2 cm into smaller pieces, facilitating their passage from
the body. Typically, ESWL is conducted on an outpatient basis, eliminating the
need for a hospital stay. It is particularly effective for relatively smaller
urinary stones, which are prevalent among stone-afflicted patients. The shock
wave generators employed in this method include electrohydraulic,
piezoelectric, and electromagnetic devices.
End Use Insights
The "Hospitals & Clinics" sector
secured a substantial share of revenue in 2023, attributed to hospitals'
investments in expanding their surgical infrastructure, the rise in kidney
stone treatments conducted within hospital settings, and the establishment of
new hospitals in various regions. Furthermore, the segment's growth is
significantly influenced by the favorable reimbursement policies provided by
On the other hand, the "Ambulatory Surgical
Centers (ASCs)" category is anticipated to experience the most rapid CAGR
throughout the projected period. When dealing with large obstructive urinary
stones, surgical removal becomes a necessary option. Ambulatory surgical
centers are gradually gaining popularity due to their time-saving and
cost-effective treatment alternatives, which reduce extended hospital stays.
Technological advancements in the field of surgery, including the availability
of minimally invasive tools such as endoscopes and precision instruments,
enable urologists to carry out painless stone removal procedures. The
preference for ambulatory surgical centers for treating urinary stones is
expected to be notably higher in developed countries like the United States,
Canada, the United Kingdom, and Germany, primarily because of their convenient
Download Free Sample Report
In 2023, North America emerged as the dominant
force in the market, capturing the largest share of revenue. This can be
attributed to various factors, including the increasing incidence of stone
formations leading to urolithiasis, a heightened risk of end-stage renal
disease within the population, and the continual approval of new products, all
of which are expected to be key drivers of market growth. According to the 2021
guidelines from the Canadian Urological Association, nephrolithiasis affects
approximately 10-12% of men and 7-8% of women worldwide, with a gradual
increase in urolithiasis prevalence, despite some regional variations.
Furthermore, as per data from the Centers for Disease Control and Prevention
(CDC), kidney disorders rank prominently among the causes of death in the
United States. A significant portion of the 37 million adults with chronic
kidney disease (CKD) in the U.S. remains undiagnosed. Additionally, the region
is witnessing an expanding awareness among the patient population regarding the
availability of new treatment options for stone-related ailments, alongside the
accessibility of medical devices, further fueling market growth in North
Conversely, the Asia Pacific region is anticipated
to experience the swiftest CAGR over the forecast period. The prevalence of
kidney stones in this region is on the rise due to a combination of factors,
including shifts in dietary patterns, lifestyle changes, and variations in
climate. As indicated by data from the National Center for Biotechnology
Information (NCBI), it is projected that the prevalence of kidney stones will
reach 14.3% in China and 12.7% in India by the year 2030. Moreover, healthcare
expenditure in the region is undergoing rapid expansion, driven by increased
awareness among governments and individuals about the significance of good
health. This is, in turn, bolstering the market, as patients are more inclined
to seek treatment for kidney stones in response to these developments.
- In July 2022, Calyxo, a company specializing in
technology for non-surgical kidney stone removal, announced the successful
closure of its Series C investment round, raising a total of $32.7 million.
This California-based company, Calyxo, developed the CVAC Aspiration system,
with the objective of eliminating kidney stones without the need for surgery.
This innovative system employs a combination of irrigation and aspiration
techniques to achieve this.
- In January 2022, the FDA granted breakthrough
designation to Applaud Medical's Acoustic Enhancer technology, as per an
official statement. San Francisco-based Applaud Medical introduced this
Acoustic Enhancer technology, designed for use alongside ureteroscopy with
laser lithotripsy (URS-LL) for the fragmentation of calcium-based urinary
stones that cause obstruction or are deemed to pose a significant risk of
future complications by urologists or other qualified medical professionals.
These stones should be between 6mm and 20mm in diameter.
- Furthermore, in March 2021, Boston Scientific and a
unit of Baring Private Equity Asia (BPEA) entered into a binding agreement,
with Boston Scientific agreeing to make an upfront cash payment of $1.07
billion to acquire Lumenis' global surgical business. This strategic
acquisition enabled Boston Scientific to expand its global portfolio of kidney
stone management products.
- In June 2020, Olympus Corporation introduced the
Soltive Laser System, a novel thulium fiber laser application specifically
designed for soft tissue procedures and stone lithotripsy.
Key Market Players
- Allengers Medical Systems Ltd
Storz SE & Co KG
By Treatment Type
By End Use
- Extracorporeal Shock Wave Lithotripsy (ESWL)
- Intracorporeal Lithotripsy
- Percutaneous Nephrolithotomy
- Hospitals & Clinics
- Ambulatory Surgical Centers
- North America
- South America
- Middle East & Africa
In this report, the Global Urolithiasis Management
Devices Market has been segmented into the following categories, in addition to
the industry trends which have also been detailed below:
- Urolithiasis Management Devices Market, By Treatment Type:
o Extracorporeal Shock Wave Lithotripsy (ESWL)
o Intracorporeal Lithotripsy
o Percutaneous Nephrolithotomy
- Urolithiasis Management Devices Market, By End Use:
o Hospitals & Clinics
o Ambulatory Surgical Centers
- Urolithiasis Management Devices Market, By
o North America
§ United States
§ United Kingdom
§ South Korea
o South America
o Middle East & Africa
§ South Africa
§ Saudi Arabia
Company Profiles: Detailed analysis of the major companies present in the Global Urolithiasis
Management Devices Market.
Global Urolithiasis Management Devices market report
with the given market data, Tech Sci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
- Detailed analysis and profiling of additional
market players (up to five).
Global Urolithiasis Management Devices Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]